Literature DB >> 3877316

Positron emission tomography of the heart.

S R Bergmann, K A Fox, E M Geltman, B E Sobel.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 3877316     DOI: 10.1016/0033-0620(85)90014-3

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  7 in total

1.  Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; S Nishizawa; N Sadato; E Tadamura; S Ono
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

Review 2.  Hibernation and myocardial ischemia: clinical detection by positron emission tomography.

Authors:  N G Uren; P G Camici
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 3.  Clinical applications of assessments of myocardial substrate utilization with positron emission tomography.

Authors:  S R Bergmann
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

Review 4.  Imaging of myocardial metabolism by positron emission tomography.

Authors:  P Rigo; C de Landsheere; P Melon; H Kulbertus
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 5.  Positron emission tomography. Diagnostic and therapeutic implications in human myocardial ischemia.

Authors:  H R Schelbert
Journal:  Int J Card Imaging       Date:  1987

6.  Cardiac ischemia. Part I--Metabolic and physiologic responses.

Authors:  G A Langer; J N Weiss; H R Schelbert
Journal:  West J Med       Date:  1987-06

7.  Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction.

Authors:  N Tamaki; E Tadamura; T Kudoh; N Hattori; Y Yonekura; R Nohara; S Sasayama; K Ikekubo; H Kato; J Konishi
Journal:  Eur J Nucl Med       Date:  1996-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.